Metapneumovirus strains and their use in vaccine...

Details Metapneumovirus strains and their use in vaccine... Metapneumovirus strains and their use in vaccine...

2003-02-21

2008-11-11

Campell, Bruce (Department: 1648)

Chemistry: molecular biology and microbiology

Virus or bacteriophage, except for viral vector or...

Recovery or purification

Reexamination Certificate

active

07449324

ABSTRACT:
The present invention provides an isolated mammalian negative strand RNA virus, metapneumovirus (MPV), within the sub-family Pneumoviridae, of the family Paramyxoviridae. The invention also provides isolated mammalian negative strand RNA viruses identifiable as phylogenetically corresponding or relating to the genus Metapneumovirus and components thereof. In particular the invention provides a mammalian MPV, subgroups and variants thereof. The invention relates to genomic nucleotide sequences of different isolates of mammalian metapneumoviruses, in particular human metapneumoviruses. The invention relates to the use of the sequence information of different isolates of mammalian metapneumoviruses for diagnostic and therapeutic methods. The present invention relates to nucleotide sequences encoding the genome of a metapneumovirus or a portion thereof, including both mammalian and avian metapneumovirus. The invention further encompasses chimeric or recombinant viruses encoded by said nucleotide sequences. The invention also relates to chimeric and recombinant mammalian MPV that comprise one or more non-native or heterologous sequences. The invention further relates to vaccine formulations comprising mammalian or avian metapneumovirus, including recombinant and chimeric forms of said viruses. The vaccine preparations of the invention encompass multivalent vaccines, including bivalent and trivalent vaccine preparations.

REFERENCES:
patent: 5166057 (1992-11-01), Palese et al.
patent: 5824307 (1998-10-01), Johnson
patent: 5854037 (1998-12-01), Palese et al.
patent: 5869036 (1999-02-01), Belshe et al.
patent: 6146642 (2000-11-01), Garcia-Sastre et al.
patent: 6180398 (2001-01-01), Klein et al.
patent: 2002/0155581 (2002-10-01), Murphy et al.
patent: 2003/0232061 (2003-12-01), Fouchier et al.
patent: 2004/0005544 (2004-01-01), Fouchier et al.
patent: 2004/0005545 (2004-01-01), Fouchier et al.
patent: 2004/0142448 (2004-07-01), Murphy et al.
patent: 2004/0229219 (2004-11-01), Gallagher
patent: 2004/0241188 (2004-12-01), Collins et al.
patent: 2005/0019891 (2005-01-01), Fouchier et al.
patent: 2005/0053919 (2005-03-01), De Jong et al.
patent: 2005/0118195 (2005-06-01), De Jong et al.
patent: 2005/0142148 (2005-06-01), Fouchier et al.
patent: 0 702 085 (1996-02-01), None
patent: 0 780 475 (1997-06-01), None
patent: 01200213.5 (2001-01-01), None
patent: 01203985.5 (2001-10-01), None
patent: 2 801 607 (1999-11-01), None
patent: WO 89/10405 (1989-11-01), None
patent: WO 93/14207 (1993-07-01), None
patent: WO 96/34625 (1996-11-01), None
patent: WO 97/06270 (1997-02-01), None
patent: WO 97/12032 (1997-04-01), None
patent: WO 97/34008 (1997-09-01), None
patent: WO 98/02530 (1998-01-01), None
patent: WO 98/13501 (1998-04-01), None
patent: WO 98/53078 (1998-11-01), None
patent: WO 99/02657 (1999-01-01), None
patent: WO 99/15672 (1999-04-01), None
patent: WO 00/20600 (2000-04-01), None
patent: WO 01/04320 (2001-01-01), None
patent: WO 01/38497 (2001-05-01), None
patent: PCT/NL02/00040 (2002-01-01), None
patent: WO 02/057302 (2002-07-01), None
patent: WO 03/043587 (2003-05-01), None
patent: WO 03/072720 (2003-09-01), None
patent: WO 03/097089 (2003-11-01), None
patent: WO 2004/057021 (2004-07-01), None
patent: WO 2005/014626 (2005-02-01), None
Van Den Hoogen et al., A newly discovered human pneumovirus isolated from young children with respiratory tract disease, Nature Medicine, Jun. 2001, vol. 7, No. 6, p. 719-724.
Osterhaus et al., Influenza B Virus in Seals, Science, May 2000, vol. 288, p. 1051-1053.
U.S. Appl. No. 09/152,845, filed Sep. 14, 1998, Garcia-Sastre et al.
Abman et al. Role of respiratory syncytial virus in early hospitalizations for respiratory distress of young infants with cystic fibrosis. J Pediatr. Nov. 1988;113(5):826-30.
Ahmadian et al. Detection and characterization of proteins encoded by the second ORF of the M2 gene of pneumoviruses. J Gen Virol. Aug. 1999;80 ( Pt 8):2011-2016.
Bayon-Auboyer et al. Comparison of F-, G- and N-based RT-PCR protocols with conventional virological procedures for the detection and typing of turkey rhinotracheitis virus. Arch Virol. 1999;144(6):1091-1109.
Bayon-Auboyer et al. Nucleotide sequences of the F, L and G protein genes of two non-A
on-B avian pneumoviruses (APV) reveal a novel APV subgroup. J Gen Virol. Nov. 2000;81(Pt 11):2723-2733.
Beare et al. Trials in man with live recombinants made from A/PR/8/34 (H0 N1) and wild H3 N2 influenza viruses. Lancet. Oct. 18, 1975;2(7938):729-32.
Beeler et al. Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function. J Virol. Jul. 1989;63(7):2941-50.
Bentley et al. Human immunoglobulin variable region genes—DNA sequences of two V kappa genes and a pseudogene. Nature. Dec. 25, 1980;288(5792):730-3.
Botts and Takashi et al. On the mechanism of energy transduction in myosin subfragment 1. Proc Natl Acad Sci U S A. Apr. 1984;81(7):2060-4.
Bridgen et al. Rescue of a segmented negative-strand RNA virus entirely from cloned complementary DNAs. Proc Natl Acad Sci U S A. Dec. 24, 1996;93(26):15400-4.
Buchholz et al. Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J Virol. Jan. 1999;73(1):251-9.
Buys et al. 1980, Turkey 28:36-46.
Cavanagh et al. Pneumovirus-like characteristics of the mRNA and proteins of turkey rhinotracheitis virus. Virus Res. Oct. 1988;11(3):241-56.
Collins et al. Characterization of a virus associated with turkey rhinotracheitis. J Gen Virol. Apr. 1988;69 ( Pt 4):909-16.
Collins et al. Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5′ proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development. Proc Natl Acad Sci U S A. Dec. 5, 1995;92(25):11563-7.
Collins et al., 1993, Avian Pathology, 22:469-79.
Cook et al., Avian Pathol. 1988, 17:403-10.
Cook et al., 1993, Avian Pathology, 22:257-73.
Domachowske et al. Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment. Clin Microbiol Rev. Apr. 1999; 12(2):298-309. Review.
Durbin et al. Human parainfluenza virus type 3 (PIV3) expressing the hemagglutinin protein of measles virus provides a potential method for immunization against measles virus and PIV3 in early infancy. J Virol. Aug. 2000;74(15):6821-31.
Durbin et al. Recovery of infectious human parainfluenza virus type 3 from cDNA. Virology. Sep. 1, 1997;235(2):323-32.
Ennis et al. Recombination of influenza A virus strains: effect on pathogenicity. Dev Biol Stand. 1976;33:220-5.
Evans AS (ed.) Viral infections of Humans, Epidemiology and Control. 3rd edition, pp. 22-28, Plenum Publishing Corp. New York, 1989.
Falsey AR., Noninfluenza respiratory virus infection in long-term care facilities. Infect Control Hosp Epidemiol. Oct. 1991;12(10):602-8. Review.
Fields et al., eds,Fields Virology, 2nded., vol. 1, Raven Press, New York, 1990, pp. 1045-1072.
Flint et al.,Principles of virology, Molecular Biology, Pathogenesis and Control. ASM Press 2000, pp. 25-56.
Florent et al. RNAs of influenza virus recombinants derived from parents of known virulence for man. Arch Virol. 1977;54(1-2):19-28.
Garvie et al. Outbreak of respiratory syncytial virus infection in the elderly. Br Med J. Nov. 8, 1980;281(6250):1253-4.
Giraud et al. Turkey rhinotracheitis in France: preliminary investigations on a ciliostatic virus. Vet Rec. Dec. 13, 1986;119(24):606-7.
Glezen et al. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr. May 1981;98(5):708-15.
Groothuis et al. Respiratory syncytial virus infection in children with bronchopulmonary dysplasia. Pediatrics. Aug. 1988;82(2):199-203.
Groothuis et al. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk inf

Affiliated with

Also associated with

Rating

Metapneumovirus strains and their use in vaccine... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Metapneumovirus strains and their use in vaccine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Metapneumovirus strains and their use in vaccine... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4023528